Case Reports
doi: 10.1002/1097-0142(197510)36:4<1305::aid-cncr2820360417>3.0.co;2-#.
Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases
- PMID: 1175129
- DOI: 10.1002/1097-0142(197510)36:4<1305::aid-cncr2820360417>3.0.co;2-#
Item in Clipboard
Case Reports
Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases
Cancer.
1975 Oct.
Abstract
A 77-year-old white man with 64 intracutaneous melanoma metastases and a pulmonary metastatic deposit was treated with immunotherapy. Over an 8-month period, 17 intracutaneous lesions were inoculated with BCG. All 17 injected lesions and all 47 uninjected intracutaneous lesions resolved; no new nodules appeared and the pulmonary metastasis regressed (greater than 50%). This is the first documented case of a pulmonary metastatic focus responding to intralesional BCG therapy of intracutaneous metastases.
Similar articles
-
Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.Aust N Z J Surg. 1977 Jun;47(3):362-5. doi: 10.1111/j.1445-2197.1977.tb04303.x. Aust N Z J Surg. 1977. PMID: 269705
-
Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.Cancer. 1975 Feb;35(2):514-20. doi: 10.1002/1097-0142(197502)35:2<514::aid-cncr2820350233>3.0.co;2-f. Cancer. 1975. PMID: 234291
-
The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.Cancer. 1975 Mar;35(3):756-77. doi: 10.1002/1097-0142(197503)35:3<756::aid-cncr2820350331>3.0.co;2-z. Cancer. 1975. PMID: 234295
-
Developments in Intralesional Therapy for Metastatic Melanoma.Cancer Control. 2016 Jan;23(1):12-20. doi: 10.1177/107327481602300104. Cancer Control. 2016. PMID: 27009452 Free PMC article. Review.
-
BCG, levamisole and transfer factor in the treatment of cancer.Prog Exp Tumor Res. 1980;25:178-92. doi: 10.1159/000403181. Prog Exp Tumor Res. 1980. PMID: 6986631 Review. No abstract available.
Cited by
-
Progression of cutaneous melanoma: implications for treatment.Clin Exp Metastasis. 2012 Oct;29(7):775-96. doi: 10.1007/s10585-012-9521-1. Epub 2012 Aug 15. Clin Exp Metastasis. 2012. PMID: 22892755 Free PMC article. Review.
-
Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology.Crit Rev Oncog. 2016;21(1-2):65-73. doi: 10.1615/CritRevOncog.2016017124. Crit Rev Oncog. 2016. PMID: 27481003 Free PMC article. Review.
-
Recombinant BCG therapy suppresses melanoma tumor growth.Ann Surg Oncol. 1995 Nov;2(6):542-9. doi: 10.1007/BF02307089. Ann Surg Oncol. 1995. PMID: 8591086
-
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.World J Surg. 1977 Sep;1(5):555-83. doi: 10.1007/BF01556181. World J Surg. 1977. PMID: 272083 No abstract available.
-
Combined modality therapy of malignant melanoma.World J Surg. 1979 Jul 30;3(3):329-43. doi: 10.1007/BF01556586. World J Surg. 1979. PMID: 382647 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources